Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 1/2 3Phase 1 3Phase NA 2Phase 3 2Phase 2 2Phase 2/3 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Neoplasms 1Lymphoma, Non-Hodgkin 1Keratosis, Actinic 1Hodgkin Disease 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Niacinamide × Clear all
NCT07049068 2025-09-15

Comparison of Nicotinamide Treatments for Actinic Keratosis

Federal University of Rio Grande do Sul

Phase 1 Completed
74 enrolled
Dermatologic

Keratosis, Actinic

NCT07119996 2025-08-13

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT00691210 2020-11-20

SAHA

Columbia University

Phase 1 Completed
40 enrolled 13 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡